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Background and purpose: Coronary heart disease (CHD) and stroke are
the leading causes of death worldwide, although these are preventable dis-
eases. In order to set priorities for public health policies, we sought to assess
and compare within a single cohort, CHD and stroke populationattributable
risks (PARs) for various cardiovascular risk factors.
Methods: The PRIME study is a multicenter prospective population-based
cohort of men living in France or Northern Ireland, aged 50-59 in 1991-93,
and followed over 10 years to record CHD (coronary death, myocardial infarc-
tion (MI), and unstable angina) and stroke.
Results: The sample comprised 9701 men, free of CHD and stroke at base-
line. During the followup, 410 and 118 cases of CHD and stroke occurred.
After adjustment for age, centre, antihypertensive and lipid-lowering treat-
ments, alcohol consumption and other significant cardiovascular risk factors,
PARs for CHD were 21.1% (high blood pressure), 14.8% (smoking), 11.1%
(hypercholesterolemia), 9.8% (low HDL-cholesterol), 5.4% (obesity) and
1.9% (diabetes). The overall PAR for CHD, referring to the presence of at
least one of the above detailed risk factors reached 71.2% (79.1% for coronary
death and MI). Adjusted PARs for stroke were 32.8% (high blood pressure),
15.9% (smoking) and 6.4% (diabetes), with no significant impact of the other
risk factors. The overall PAR for stroke was 43.7% (44.6% for ischemic
stroke).
Conclusions: The impact of traditional cardiovascular risk factors on CHD
and stroke are different. As prevention should primarily focus on factors
exhibiting high PARs for both diseases, high blood pressure and smoking are
the best targets.
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Cadiovascular variability and spontaneous baroreflex sensitivity in
type 2 diabetes (experience in Morraccan patients) 
Zineb El Honsali, Meryem Alj, Faima Waderrahmane
CHU Ibn Rochd, Casablanca, Maroc
Enhanced sympathetic activity is a potential cause of increased risk of car-
diovascular complications during treatment in type 2 diabetes. Spectral anal-
ysis of heart rate and blood pressure has considerable potential in assessing the
role of autonomic nervous system fluctuations in healthy individuals and
patients, as well as spontaneous baroreflex sensitivity (SBS) by means of the
α index. The aim of the present study was to investigate if type 2 diabete
without diagnosis of autonomic neuropathy is accompanied by alterations in
cardiovascular variability and SBS.
Methods: Spectral analysis of RR interval and blood pressure variability
were obtained during undisturbed supine rest in 7 healthy control subject
(controls) and 7 patients with type 2 diabetes without diagnosis of autonomic
neuropathy.The two group were matched for BMI and age. 
Result: type 2 diabete without diagnosis of autonomic neuropathy had
shorter RR interval (804±46 ms) compared with controls (939±37ms,
p<0.001for both comparisons). In type 2 diabete without diagnosis of auto-
nomic neuropathy total variance of RR was reduced (493±162 ms,p<0.05)
and spectral analysis of RR variability showed an increased low frequency
normalized units (75±5. p<0.02, index of sympathetic modulation) a
decreased high frequency normalized units (25±5, p<0.001, index of vagal
modulation) compared with control as well as an increased LF/HF ratio
(3.1±0.9, p<0.001) systolic blood pressure variance in type 2 diabete without
diagnosis of autonomic neuropathy was twofold greater than in controls
(31±8, p<0.007) as well as reduced the LF component (5±0.5 mmHg²,
p<0.0036). α index was significantly reduced in type 2 diabete without diag-
nosis of autonomic compared with controls (5.9± 0.4 and 11±2 ms/mmHg
respectively, p<0.003) 
Conclusion: type 2 diabete without diagnosis of autonomic neuropathy is
characterized by increase in cardiac and vasomotor sympathetic drive. The
increased sympathetic activity and decreased of SBS may play an important
role in the development of hypertension as well as may represents and
increase cardiovascular risk in patients with type 2 diabete 
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Characteristics and outcome of patients hospitalized for lower extre-
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Background: Lower extremity peripheral artery diseases (PAD) is a
source of disability and is often associated with other cardiovascular diseases.
Although beta-blockers may be required for associated coronary artery disease
their use in PAD is still controversial, suspected of worsening the PAD. Our
goal was to assess the prescription of beta-blockers at admittance and dis-
charge of patients hospitalized for PAD and to analyze their effect on mor-
bidity and mortality at one year, from the COPART Registry, a prospective
multicenter study with patients consecutively recruited from vascular medicine
departements of 4 academic hospitals in France between 2006 and 2010.
Methods: COPART registry included patients >18 years, with either inter-
mittent claudication associated with an abnormal ABI, and/or an arterial ste-
nosis >50% or ischaemic rest pain, or ulceration and gangrene or acute lower-
limb ischaemia. We compared characteristics and outcome between patients
with or without bêtablocker (BB) at admittance and at discharge.
Results: Among the 1267 patients of the COPART registry, 328 (26%)
were treated with BB at admittance. History of blood hypertension and acute
myocardial infarction (AMI) were independent factors for BB prescription
(OR 2.60 and 3.02; p <10-4, respectively). At discharge, only AMI history
favored prescription of BB (OR 3.11, P <10-4). History of chronic obstructive
pulmonary disease and PAD with ulcer had a negative relationship with pre-
scription of BB at admittance (OR: 0.57 and 0.55 ; p<0.05, respectively) and
discharge (OR: 0.57 and 0.64 ; p<0.05, respectively). 1-year-mortality of
patients with BB did not differ from thoose without (22.7% vs 22.5%;
p=0.954; OR 1.08 95%CI [0.77-1.5]). Concerning the 1-year-amputation rate
no difference was found neither: 4.0% of patients with BB vs 6.2% without
(p=0.142) OR 0.63 95%CI [0.33-1.19].
Conclusion: Patients hospitalized for PAD can safely carry on with their
BB treatment with no increase of 1-year-mortality nor 1-year-amputation rate.
Base on these safety data prospective study should be conducted to assess the
effect of BB on long-term mortality in PAD
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Contributions of transcutaneous oxygen pressure at exercise in eva-
luating buttocks and calf intermittent claudication related to periphe-
ral arterial disease: comparison with ankle-brachial index.
Jerome Hourdain (1), Michel Bartoli (1), Pierre Abraham (2), Pierre
Edouard Magnan (1), Gabrielle Sarlon (1)
(1) Hôpital la Timone, Marseille, France – (2) CHU Angers, Explorations
fonctionnelles vasculaires, Angers, France
Objective: Measurement of post exercice ankle-brachial index (ABI),
diagnostic reference method of intermittent claudication related to peripheral
arterial disease (PAD), has limitations.This study aims to compare transcuta-
neous oxygen pressure (TCPO2) to ABI in the etiologic diagnosis of intermit-
tent claudication.
Methods: A prospective inclusion of 15 patients, with symptoms of inter-
mittent claudication, carrying at least one arterial lesion on CT (>50%) of the
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iliac arteries, femoral, popliteal arteries or legs, have been a measurement of
ABI and TCPO2, during treadmill test, in the buttock and calf, before and
after angioplasty. A drop in ABI > 20% and a decrease in TCPO2 with respect
to the rest stored to changes in the thorax (Delta from Rest Oxygen Pressure
or DROP), < -15 mm Hg, defined the cut-off points.
Results: DROP showed a sensitivity 86%, a specificity 81%, with a signif-
icant correlation to the fall of ABI (r=0,5187, p=0,001). ABI and TCPO2
were significantly related to the presence of intermittent claudication, respec-
tively 40±4% vs 18±4% (p<0,001) and –30±2 mm Hg vs –10±1 mm Hg
(p<0,001). Unlike ABI, the normalization of TCPO2 after revascularization
were significantly bound to the improvement of clinical (–31±3 mm Hg vs
–8±1 mm Hg, p<0,001). After revascularization, post stress ABI, TCPO2 in
the calf and buttock were significantly improved (0,21±0,34 p=0,03, 12±11
mm Hg p<0,001, 28±19 mm Hg p=0,001) and without treatment, the results
were not significantly different (0,04±0,19 p=0,63, 8±13 mm Hg p=0,14,
5±11 mm Hg p=0,14).
Conclusion: DROP and ABI fall, at exercise, in patients related intermit-
tent claudication, are correlated, reproducible and effective in the diagnosis
of PAD. Exercice TCPO2 presents a better association with the clinic and
allows exploration of the proximal ischemia, not with ABI. TCPO2, during
treadmill test, seems to be interesting in the exploration of intermittent clau-
dication.
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Tristan Mirault (1), Clémence Chamoin (1), Jean-Pierre Cambou (2),
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Background: Lower extremity peripheral artery diseases (PAD) preva-
lence and severity increase with age. However few data on elderly patients
hospitalized for PAD are available. We aim to assess characteristics and out-
come of ≥75-year-old patients hospitalized for PAD
Methods: Characteristics and outcome comparisons between <75 &
≥75-year-old Patients from the COPART Registry, a prospective (2006-
2010) study from 4 french academic hospital vascular medicine units with
patients consecutively recruited >18 years, with either intermittent claudi-
cation associated with an abnormal ABI, and/or an arterial stenosis >50%
or ischaemic rest pain, or ulceration and gangrene or acute lower-limb
ischaemia. * p<0.05
Results: 546/1,241 (44%) patients were ≥75. Hyperlipemia (43 vs
62%,*) or active tobacco addiction (50 vs 84%,*) were lower but no differ-
ence for high blood pressure or diabetes. They suffered less of AMI (17 vs
24%,*) or COPD (12 vs 16%,*), but more of heart failure (17 vs 9%,
p<0.05) or AF (32 vs 11%, p<0.05). PAD were more severe, more arterial
ulcers (54 vs 39%,*), ischaemic rest pain (24 vs 35%,*), less intermittent
claudication (11 vs 37%,*) but same rate of acute limb ischaemia. Despite
same diabetes rate we found more isolated distal lesion (79 vs 52%,*). More
minor amputations were performed (11 vs 7%,*) and less bypass surgeries
(9 vs 15%,*) but similar rate of angioplasty or major amputation. Cardio-
vascular treatments differed for VKA (20 vs 13%,*) and betablockers (22 vs
31%,*). Intrahospital & 1-year mortalities were higher (6.8 vs 2.9%,* and
35.3 vs 13.8%,*) respectively.
Conclusion Patients ≥75-year-old hospitalized for PAD had poor short &
long-term outcome. Clinical presentation was more advanced with predomi-
nant under-knee artery lesions. Along with higher cardioembolism risk (AF
and heart failure) that could explain the low rate of bypass and higher ampu-
tation. This result confirms the need to detect PAD in elderly at earlier stage
to improve their actual very bad outcome.
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Specific characteristic of acute upper limb arterial ischemia: analysis
of a 114 patients cohort
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Rossi (1), Audrey Stansal (1), Jean-Marc Alsac (2), Marc Sapoval (3),
Emmanuel Messas (1)
(1) Hôpital Européen Georges Pompidou (HEGP), Médecine Vasculaire,
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Pompidou (HEGP), Radiologie interventionnelle cardiovasculaire, Paris,
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Background: Acute upper limb arterial occlusion is an uncommon condi-
tion in peripheral arterial disease. Only small series or case reports can be
found from a review of the literature. We aimed to characterize the clinical
background and etiologies from these patients seen in our institution.
Methods: 114 consecutive patients hospitalized in our vascular medicine
unit were identified from electronic database (using ICD10 code I.742) since
2000. Diagnosis was established by 2 independent observers based on the
review of each medical report and examinations performed.
Results: Mean age was 56.2±17.4 with 52.6% males. The main cardiovas-
cular (CV) risk factor was smoking (56%) then hypertension (46%) and
hypercholesterolemia (37%). Only 15% had family history of CV disease, and
10% diabetes. The leading cause was professional disease or Hammer Syn-
drome (13%) then cardioembolism (12%) (AF, flutter, intraventricular
thrombus and atherosclerotic plaque embolism sub-clavian stenosis most
oftenly), iatrogenic disease (11%) (intraarterial drug infusion, chemotherapy,
radiotherapy), Thromboangeitis obliterans (9%), connective tissue diseases
(systemic sclerosis, rheumatoid arthritis) 7%, malignancy (myeloproliferative
disorders, solid neoplasia) 7%, thoracic outlet syndrom 5%, thrombophilia
5%, large vessels vasculitis (Takayasu, Giant cell disease) 3% along with par-
adoxical embolism 3%. 13% had no etiology although a 3 years follow-up and
wide explorations
Conclusion: We reported here one of the widest cohort of acute upper
limb arterial occlusion. Our results suggest that the occurrence of an upper
limb arterial occlusion should lead to a very exhaustive investigations, as the
distribution of the aetiologies completely differs from those found in lower
limb. Hammer syndrome and cardioembolism are the most prevalent causes
before atherosclerosis. Iatrogenic disease should not be ignored including drug
adverse event, or intraarterial infusion. Unfortunately, 1 of 7 patients remains
idiopathic.
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Opportunistic screening of abdominal aortic aneurysm during hospi-
talization: the OSCAAAR (Opportunistic SCreening of Abdominal
Aortic AneuRysm) study.
Aurélien Leclerc (1), Thomas Cautres (2), Iléana Désormais (1), Marc
Laskar (1), Philippe Lacroix (1), Victor Aboyans (2)
(1) CHU Limoges, CTCV Angiologie, Limoges, France – (2) CHU
Limoges, Cardiologie, Limoges, France
Background: Population screening of abdominal aorta aneurysm (AAA) is
recommended in many countries including France, based on several trials
which have demonstrated the benefits of AAA screening, especially in men.
However, such a screening program is not yet well implanted in our country.
An opportunistic screening of AAA during any medical contact may be an
alternative in the absence of a systematic approach. We hypothesized that
AAA screening during hospitalization could be effective. We aimed to assess
the prevalence of AAA in patients at risk who are hospitalized for any non-
cardiovascular condition in our hospital.
Methods: From February 2011 to June 2012, a total of 394 men and
109 women randomly selected accepted AAA screening by ultrasound. An
AAA was defined as an infra-renal aortic anterior-posterior diameter ≥30mm.
After analysis of the first 250 patients, screening was limited to men ≥65 years
old, since neither younger nor female patients presented an AAA.
Results: Among the 503 patients (mean age 71.2±5.4 years) we detected
an AAA in 20 cases (4%). The prevalence reached 5.5% in men ≥65 years old.
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In a logistic regression model, the factors independently associated with the
presence of AAA were: age ≥75 years (OR=4.0; p<0.01), smoking history of
more than 25 packs-years (OR=3.5; p<0.02), familial history of AAA
(OR=13.6; p<0.007), personal history of atherosclerotic disease (OR=2.5;
p=0.07) or organ transplantation (OR=59; p<0.001). Screening only men aged
from ≥65 years old with any of the above-mentioned factors would detect
AAA in 7.8% of cases, without any false negative case. 
Conclusion: A systematic screening of AAA during any hospitalization
of men ≥65 years old with at least one of the risk factors is worthwhile
and could be implemented in the absence of any population screening
program.
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Hypertension and coronary artery disease: a retrospective study in
the university hospital of Tlemcen, Algeria, department of cardiology
Fethi Moussaoui 
CHU Tlemcen, Tlemcen, Algérie
Introduction: Hypertension is a major cardiovascular risk factor, Cardio-
vascular mortality increases with the level of blood pressure. It is now widely
recognized that hypertension-related stroke is high, do not overlook the link
between hypertension and coronary artery disease, excess mortality related to
hypertension is higher for coronary events than for stroke.
Materials: Our work is retrospective together with a total of 835 patients
hospitalized in the cardiology department for ACS during the years 2010-
2011-2012.
Objective: determine the epidemiological characteristics of hypertensive
patients and the relationship between levels of blood pressure (SBP, DBP, PP)
and the prevalence ACS.
Results:  
– HTA is the dominant cardiovascular risk factor present in 50% of cases.
– 79.6% of patients were male, sex ratio 4.
– 40% of patients have an age [40 and 59].
– 60% of patients had uncontrolled hypertension at admission.
– More than half of patients were on monotherapy.
– 2/3 of patients had a pulsed pressure greater than 60 mm hg .
Conclusion: The role of hypertension on the incidence of ischemic heart
disease is constantly found.
The cardiovascular risk is dependent systolic and diastolic components of
blood pressure. It is also parallel to the level of pulse pressure (differential
PAS-PAD).
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Hypertension and diabetes mellitus in the employees of railways com-
pany in Congo – Brazzaville: screening results during the “World
Health Day” of WHO in 2013
Bertrand Ellenga Mbolla (1), Thierry Raoul Alexis Gombet (1), Henri
Germain Monabeka (2), Suzy Gisèle Kimbally-Kaky (1), Benjamin
Longo-Mbenza (3)
(1) CHU Brazzaville, Cardiologie, Brazzaville, Congo – (2) Faculté des
sciences de la santé, Université Marien Ngouabi, Département de méde-
cine, Brazzaville, Congo – (3) Faculty of health sciences, Walter Sisulu
University, Mthatha, Afrique du Sud
Aim: To determine the frequency of hypertension (HT), diabetes and obe-
sity/overweight among the Railwaymen in Congo – Brazzaville.
Methods: This is a screening survey, conducted during the “World Health
Day 2013” of WHO in April 2013. They including the employees of “Chemin
de Fer Congo-Océan” (CFCO) the national company of railway in Congo-
Brazzaville.
Results: A total of 255 employyes divided into 231 men and 24 women
were detected. The mean age was 45±13 years (range 19-63 years). Among
them, 79 lived in rural areas (31%) and 52 were senior executives of the com-
pany (20.4%). The agents were known and treated HT in 25 cases (9.8%) and
diabetes in 3 cases (1.2%). The frequency of obesity was 7.5% (n=19) and
overweight 40.3% (n=103). The frequency of HT was 29.4% (n=75), and dia-
betes 3.5% (n=9). In multivariate analysis the factors associated with HT were
parental HT (OR=2.4; 95% CI 1.2-4.8, p<0.01), being senior (OR=3.4; 95%IC
1.8 – 6.5, p<0.001), overweight (OR=4; 95% CI 2.2 -7.1, p<0.0001), obesity
(OR=3.7; 95% CI 1.4-9.6, p<0.01) and diabetes mellitus (OR=5.5; 95% CI
1.2 –21, p=.02).
Keywords: hypertension, diabetes, overweight, railway employees, Congo
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Peripheral arterial disease in African diabetic population
Alain Essam Nloo 
Hôpital militaire Yaoundé, Cardiologie, Yaoundé, Cameroun
Peripheral arterial disease (PAD) is correlated to conventional cardio-
vasculars risk factors. Diabetic patients are reported to be more exposed to
this disease. The aim of the study was to screen PAD in an African popu-
lation of diabetic subjects. We assessed epidemiological, clinical and ultra-
sonic aspect of these PAD. 308 subjects were included. After clinical
examination, we assessed the distribution of ankle-brachial index (ABI).
Arterial duplex ultrasonography exam was performed to patients with
abnormal ABI. Mean age was 55±13. There were 45.5% men and 54.5%
women. Type 2 diabete mellitus was involved in 91.6% cases. We had
41.6% cases of hypertension, 19.5% smokers. 3.2% of patients were having
claudication,10.6% with low ABI <0.90. 11.3% with high ABI > 1.30.
Arterial duplex ultrasonography showed 26% PAD (IC 95% 19.8% 34.3%).
Distal vessels were commonly involved. History of smoking and low ABI
< 0.90 were predictor of PAD. PAD is a common complication of DM.
Men and women are equally involved. PAD Screening using ABI could be
used for early diagnosis.
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Epidemiological and therapeutic peculiarities of hypertensive patients
in south Algerian
Abdallah Ghalmi 
Hôpital militaire de Bechar, Cardiologie, Bechar, Algérie
High blood pressure (HBP) is a public health problem. More than a quarter
of the world's adult population have high blood pressure, this proportion is
gradually increasing and sub-Saharan Africa is not an exception. This increase
is due to the growth and aging of the population, but also the surge in the
number of obese persons due to urbanization and changing lifestyle. Target
organ damage is more common, due to delayed and inadequate therapeutic.
Coronary syndrome, heart failure, stroke and renal failure often occurs. The
mainstay of treatment is the use of thiazide diuretics and calcium channel
blockers, combined with lifestyle and dietary measures (especially the reduc-
tion of sodium intake).
this monocentric prospective study shows the epidemiological and thera-
peutic peculiarities of 500 hypertensives patients followed in bechar hospital
in southern Algeria.
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Factors correlated with left ventricular mass in hypertensive patients
Naouar Benyassine, Salwa El Karimi, Mostapha El Hattaoui
CHU Mohamed XI, Cardiologie, Marrakeh, Maroc
Left ventricular hypertrophy (LVH) is an independent risk factor in hyper-
tensive patient. 
The aim.: Of our study is to evaluate prospectively the relationship
between left ventricular mass and clinical, echocardiographical and ambula-
tory blood pressure data in hypertensive subjects.
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Methods: We studied 100 hypertensive patient who underwent clinical and
laboratory investigation, echocardiography and 24 hours ambulatory blood
pressure monitoring. Correlations were made between these data and left ven-
tricular mass. 
Results: Clinical data, which correlated well with left ventricular mass,
were duration of hypertension, systolic arterial pressure and pulse arterial
pressure. In echocardiography left atrial area and left ventricular dysfunc-
tion correlated significatively with left ventricular mass. Data from
24 hours blood pressure monitoring as daytime systolic pressure, night-
times diastolic pressure, ambulatory systolic pressure and ambulatory
pulse pressure.
Conclusion: In hypertensive patient, left ventricular mass correlated well
with left atrial dilation and diastolic left ventricular dysfunction. It also corre-
lated with 24 hours ambulatory blood pressure monitoring data. 
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Clinical usefulness of ambulatory blood pressure monitoring to mana-
gement of hypertension
Fatima Belmourida (1), Malika Noureddine (2), Leila Azzouzi (2),
Rachida Habbal (2)
(1) CHU Ibn Rochd Casablanca, Casablanca, Maroc – (2) CHU Ibn
Rochd Casablanca, Cardiologie, Casablanca, Maroc
During the last decade, ambulatory blood pressure monitoring became a
technique useful by practicing physicians in assessing certain problems in
hypertension. 
Our aims were to study the practicing of physicians regarding ambulatory
monitoring of blood pressure and to assess changes in patient management
after this study.
The main indications for ordering the test included borderline hypertension
(28%), assessment of blood pressure control during drug therapy (26%), eval-
uation for “white coat” hypertension (23%), and drug-resistant hypertension
(15%). 
After the ambulatory blood pressure study, the diagnosis was changed in
41% of the patients, and antihypertensive therapy was changed in 46%. 
In 115 patients, blood pressure measured decreased from 163/92 ± 25/13
mm Hg before the ambulatory blood pressure study to 152/83 ± 26/11 mm Hg
after the study (P=0.003 for systolic blood pressure and P < 0.001 for diastolic
blood pressure). Seventy-one percent of the patients had a lower blood pres-
sure in the office of the ambulatory blood pressure study.
In conclusion physicians use ambulatory blood pressure recordings for
appropriate indications, and data from the monitoring studies affected the
management of patients with hypertension.
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Age and echocardiographic correlates of high pulse pressure (expe-
rience of Moroccan patients) 
Zineb El Honsali, Faima Waderrahmane, Naima Baaddy
CHU Ibn Rochd, Casablanca, Maroc
The hemodynamic significance of high pulse pressure (PP) chances with
age, from high stroke volume (SV) in young, to low arterial distensibility in
older individuals. 
Objective: to analyze the age related change in the echocardiographic cor-
relates of high PP. 
Methods: Baseline data from 600 hypertensive patients were analysed.
The relationships of 24 hour PP Qwith LV mass and SV (teicholz formula)
were evaluated according to age:<30 (n=100), 30-49 (200) and >50 years
(n=300). 
Results: before age 30 years, higher 24 –hr PP, was associated with greater
LV mass, wall thickness, LV diameter, and SV (p<0.001), but not relative
wall thickness (RWT). In this age group 24 –hr PP, but not systolic blood
pressure (SBP) and sex, was selected as independent predictor of LV diameter
and SV, whereas the opposite was true for LV mass and wall thickness. In the
older group, higher PP predicted a greater LV concentricity, but the associa-
tion lost statistical significance after the adjustment for SBP and gender. 
Conclusion: Widened PP hypertension underlines a greater LV diameter
and SV in youth, and a concentric LV geometric pattern in olders, but the
latter a association is mediated by SBP 
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Left ventricular diastolic dysfunction and cardiovascular morbidity in
essential hypertension in Moroccan patients
Zineb El Honsali, Faima Waderrahmane, Meryem Alj, Naima Baaddy
CHU Ibn Rochd, Casablanca, Maroc
In essential hypertensive patients, abnormalities in both myocardial rela-
xation and passive filling, may be observed. It has been demonstrated that dia-
stolic filling alteration are associated to greater number of cardiovascular
events (CVE). 
To evaluate the prognostic significant of diastolic filling abnormalities
and their change during antihypertensive treatment, we followed 284 con-
secutive hypertensive patients under treatment (162 M, 122 F, age range
29-71 years, mean age:56±6 years), (mean follow-up of 4.6 years). In all
patients an echocardiography, including a double transmitral flow assess-
ment was performed at baseline and at follow-up. Left ventricular (LV)
end-diastolic wall thickness, diameter and transmitral flow velocity (Early
flow, Ev and atrial systolic velocity, Av) and LV mass indice (LVMI,g/m²)
were measured. Patients were divided in two groups, with or without dia-
stolic dysfunction. 
Results: In patients with diastolic dysfunction, BP values were signi-
ficantly higher in respect to patients with normal LV filling. (PAS 157
(21) vs 152 (14) mmhg, PAD 97 (13) vs 95 (9) mmhg, p<0.05), while no
significant differences were observed for age, gender distribution, body
mass index, relative wall thickness and LVMI.The cumulative number of
non fatal CVE was significantly greater in patients with diastolic dysfunc-
tion in respect to those patients with normal LV filling (15 vs 6.2%,
p=0.02).The incidence of morbid CVE was significantly greater in patients
with persistently abnormal LV filling (18%) as compared to patients with
normal pattern of diastolic filling both at baseline and during the follow-
up (18 vs 5%, p=0.002). In Cox regression analysis, controlling for BP,
gender, glycemia and smoking, age and persistence of LV hypertrophy
(LVMI>125 g/m²) conferred in increased risk of CVE, while a low age and
HR adjusted Ev-Av ratio did not result as an independent predictor of CV
morbidity. 
Conclusions: Our results confirm that diastolic filling abnormalities are
associated with an increased risk of non fatal CVE. We observed that this
association is not independent from changes in LV mass. 
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The peculiarities of changes of pulse pressure and circadian blood
pressure profile in patients with arterial hypertension
Larysa Zhuravlyova, Iryna Ilcenko 
Kharkiv National medical university, internal medicine N3, Kharkiv,
Ukraine
Purpose: to define the peculiarities of pulse pressure (PP) changes
depending on circadian blood pressure (BP) profile in patients with arterial
hypertension (AH).
Methods: 184 patients with AH stage II were examined. Among them
were 90 males and 94 females, mean age – 56.8 + 4.3 years. The mean
duration of AH was 12.4 + 5.2 years. There were 98 patients with AH
grade 2 and 86 patients with AH grade 3. 24-hr ambulatory BP monitoring
was done to all patients. Depending on the degree of BP reduction two
groups of patients were identified: «dipper» – group 1, 96 patients with
sufficient BP reduction and «non-dipper» – group 2, 88 patients with inad-
equate BP reduction.
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Results: There was a significant difference between daily mean systolic
pressure (DMSP) and daily mean diastolic pressure (DMDP) in the 1st and 2nd
groups of patients: DMSP 138.46+10.74 mm Hg and 167.66+11.52 mm Hg
(p<0,01) respectively; DMDP 72.83+10.42 mm Hg and 98.74+11.28 mm Hg
(p<0,01) respectively. The indexes of circadian PP were significantly higher in
group 2 rather than in group 1: 69.42+12.48 mm Hg and 50.68 + 10.64 mm Hg
(p<0,01) respectively. Moreover, the level of PP in the daytime was signifi-
cantly higher in group 2 than in group 1: 66,72+10,64 mm Hg and
51.28+10.36 mm Hg (p<0,01) respectively; it decreased insufficiently at
nighttime and remained significantly higher than in group 1: 64.52+9.28 mm Hg;
45.53+8.22 mmHg; (p<0,01).
Conclusions: The indexes of PP during the daytime and nighttime are sig-
nificantly higher in patients with AH and inadequate BP reduction than in
patients with a sufficient BP reduction. High PP in patients with inadequate
daily BP reduction may be a marker of worse AH prognosis, progression of
target organ damage and increased cardiovascular risk.
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The new direct oral anticoagulants in private practice: a cautious
enthusiasm.
Caroline Krieger, Boris Aleil, Mihaela Cordeanu, Sébastien Gaertner,
Corina Miréa, Dominique Stéphan
NHC, Hypertension, Maladies Vasculaires et PC, Strasbourg, France
Background: The new direct oral anticoagulants (DOA) such as dabiga-
tran or rivaroxaban are an evolution in the management of patients requiring
curative anticoagulation. However, behind the simplicity of prescribing and
monitoring, several questions remain about their daily use. The aim of this
prospective study was to measure the feelings of general practitioners (GP),
angiologists (AP) and cardiologists (CP), potential prescribers of this new
anticoagulant family.
Method: Between December 2012 and May 2013, a questionnaire
including 5 open questions and 11 questions using a positioning on an ana-
logic visual scale (AVS 0-10) was subjected to GP, AP and CP in Alsace.
Results: Responses from 199 physicians (149 GP, 28 AP and 22 CP) were
collected. Thus, 83% of GP, 82% of AP and 100% of CP currently prescribe
DOA. However, among these prescribing doctors, the feeling is not the same
and the trend of prescription is lower in GP (2.45±1.89 units AVS) than in AP
(3.63±1.76; p=0.04) and in CP (5.05±2.55; p<0.0001). The female doctors
tend to prescribe these DOA in younger patients than male doctors (respec-
tively 65.6±13.8 vs 72.3±11.3 years; p=0.03). The DOA are more considered
as progress by AP and CP (respectively 7.06±2.45 and 7.32±2.03 uAVS) than
by GP (6.06±2.66; p=0.039). The answer about the eventual replacement of
vitamin K antagonists by the DOA is very mixed whatever the practitioner
group (5.33±2.95 uAVS; p=0.223 intergroup). The arguments in favor of the
prescription are mainly the ease to use and the lack of biological monitoring
but the attitude of practitioners is very balanced by the lack of experience on
the bleeding risk and the lack of available antidote.
Conclusions: If the DOA are considered as an improvement for the studied
physicians, the enthusiasm remains cautious whatever the type of practiced
medicine. The results of new clinical trials and the clinical experience should
better appreciate the ongoing change in the field of anticoagulation.
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Use of thromboprophylaxis in medical ill patients during hospitalisa-
tion
Leila Simoné, Pierre Nazeyrollas, Anne Long, Damien Metz
Hôpital Robert Debré, Reims, France
Venous thromboembolism remains a major public health concern,
although effective prevention is available. Prevention in medical patients
remains low comparing to surgical patients. The aim of our study was to
describe thromboprophylaxis practices in our institution, to compare them
to international guidelines of ACCP 2012 and to identify determinants of
its use.
Patients hospitalized for 48 hours or more in medical departments were
screened. Risk factors for deep venous thromboembolism, cardiovascular and
bleeding risk factors and prophylaxis used were recorded. Each patient was
ranked with a score based on a risk scale, defining whether thromboprophy-
laxis was indicated (points ≥4). Appropriate adherence to the guidelines was
analyzed.
173 patients were included. Infection (40,5%), loss of autonomy (21,4%),
cardiac and respiratory failure (13,3%) were common admitting diagnosis.
The prescription did not differ among the wards. Among the 122 patients
requiring a prophylaxis, only 50% received prevention. In multivariate anal-
ysis, factors independently associated with absence of prevention were
smoking (OR 4,2; 95% CI 1,1-8,2 p=0,036) and hypercholesterolemia (OR
4,1; 95% CI 1,1-4,9 p=0,045). Recent surgery was significatively associated
with appropriate prevention (OR 0,2 ; 95% CI 0,03-0,06 p=0,023). Among the
51 patients with no indication of thromboprophylaxis, 45,1% received a pre-
vention. Acute infection (OR 5,3 ; 95% CI 1,1-29,6 p=0,05) and higher risk
score (OR 2,6 ; 95% CI 1,2-5,6 p=0,015) were associated with prevention in
multivariate analysis. Bleeding risk factors did not influence the use of pro-
phylaxis. When prescribed, the most used treatment was low-molecular-
weight heparin (74%).
Although closed to international studies, appropriate prevention rate found
in our study remains unacceptably low. Efforts should be made to develop a
systematic and regular evaluation of venous thromboembolism risk and strat-
egies to improve prevention in high-risk patients.
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Non invasive and real time evaluation of mice aortic stiffness by ultra-
fast ultrasound imaging: a new tool for evaluation of preclinical
vascular disease models
Tristan Mirault (1), Clément Papadacci (2), Blandine Dizier (3), Mickael
Tanter (2), Xavier Jeunemaitre (1), Mathieu Pernot (2), Emmanuel Messas (1)
(1) Hôpital Européen Georges Pompidou (HEGP), Médecine Vasculaire,
Paris, France – (2) ESPCI – ParisTech, Institut Langevin, Paris, France –
(3) Université Paris Descartes – Faculté de Pharmacie, Inserm U765,
Paris, France
Background: In mice, pulse wave velocity (PWV) evaluation was reported
through invasive measurement by the ratio of distance between 2 arterial can-
nula tips divided by transit time or non-invasively by MRI requiring a long
acquisition time. We evaluated the capacity of a new ultrasound ultrafast
imaging to determine non-nvasively, in real-time, the aortic PWV in mice.
Methods: Comparable aged and weighted BalbC mice (n=6) were used
with invasive arterial BP catheter allowing to measure acute pressor responses
to raising doses of phenylephrine (PE) (0.01–700 ȝg/kg) via a venous catheter
in anesthetized mice with pentobarbital. Abdominal aorta was imaged using a
conventional linear ultrasonic probe (15MHz) connected to an ultrafast
scanner acquiring at 5400 frames/s. Arterial wall tissue velocities were
computed off line and analyzed by speckle tracking technique. Results are
mean±SD
Results: We identified 2 forward waves running along the arterial
wall: one at the ECG-peak-R-wave -time of aortic diastolic blood pressure-
(PWV-DBP) and one at the ECG-end-T-wave -time of aortic systolic blood
pressure- (PWV-SBP). Heart Rate was 415±50bpm. Mean difference
between PWV-DBP and PWV-SBP was 2.3±1.4 m/s. A linear relationship
between PWV and BP was observed for the 2 PWVs ranging from 2.5-10.0 m/s
for BP from 55-265 mmHg. A linear relation of aortic BP was similar in
diastole and in systole with respective slope of 0.037±0.008m/s/mmHg and
0.035±0.010m/s/mmHg, and good fit: r²= 0.90 and 0.83 respectively
Conclusion: This new ultrafast ultrasound scanner demonstrated its capa-
bilit to visualize and calculate non invasively in real time, mice aortic PWV
at different times of cardiac cycle despite very high heart rate. Moreover, it
allows to better characterize the aortic wall biomechanical properties by eval-
uation of the PWV-BP slope. We hope that this breakthrough will allow in the
near future to better evaluate aorta biomechanical properties in preclinical
models of vascular disease.
